v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2024
Dec. 31, 2025
Cash flows from operating activities              
Net loss $ (44,741) $ (41,930)   $ (53,016) $ (468,005)    
Adjustments to reconcile net loss to net cash used in operating activities              
Depreciation       4,521 7,790    
Amortization of intangible assets       2,040 367,409    
Amortization of right-of-use assets       1,513 2,162    
Amortization of patent license       516 0    
Share-based compensation expense       13,722 21,096    
Impairment charges 0 0 $ 15,000 0 15,000 $ 40,000  
Gain on disposal of assets       (48,100) 0    
Accretion of discount on marketable securities, net       (515) (2,982)    
Change in the estimated fair value of contingent consideration 0 0   0 (18,700)    
Inventory provision       1,417 8,542    
Deferred income taxes       0 (546)    
Other       450 1,059    
Changes in assets and liabilities              
Accounts receivable, net       4,344 (4,733)    
Inventory, net       (14,467) (3,868)    
Prepaid expenses and other assets       (429) 6,809    
Accounts payable       1,156 (505)    
Accrued expenses       (1,763) (2,407)    
Deferred revenue       (423) 808    
Operating lease liabilities       2,894 (1,730)    
Other liabilities       5,866 (632)    
Net cash used in operating activities       (80,274) (73,433)    
Cash flows from investing activities              
Proceeds from disposal of assets       50,000 0    
Payment for waiver of milestone obligation       (1,900) 0    
Purchases of property and equipment       (4,598) (1,939)    
Purchases of intangible assets       (5,000) (5,000)    
Purchase of patent license       (2,056) 0    
Purchases of investments       (57,547) (117,992)    
Maturities of investments       97,031 195,448    
Net cash provided by investing activities       75,930 70,517    
Cash flows from financing activities              
Proceeds from issuance of common stock from equity plans       1,692 1,959    
Net cash provided by financing activities       1,692 1,959    
Net decrease in cash, cash equivalents, and restricted cash       (2,652) (957)    
Cash, cash equivalents, and restricted cash at beginning of period     $ 57,592 65,259 57,592    
Cash, cash equivalents, and restricted cash at end of period 62,607 56,635   62,607 56,635 57,592  
Cash and cash equivalents at end of period 61,003 54,803   61,003 54,803   $ 63,707
Restricted cash at end of period 1,604 1,832   1,604 1,832    
Cash, cash equivalents, and restricted cash at end of period $ 62,607 $ 56,635   62,607 56,635 $ 57,592 $ 65,259
Supplemental disclosure of non-cash investing and financing activities              
Right-of-use asset and lease liability recognized due to lease extension       $ 0 $ 29,575